[HTML][HTML] Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling… - … therapy Methods & …, 2016 - cell.com
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling… - … therapy. Methods & …, 2016 - pubmed.ncbi.nlm.nih.gov
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
[PDF][PDF] Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling, LPG Wheeler… - academia.edu
Replication-deficient adeno-associated virus (AAV) or lentivirus vectors are powerful tools
for delivering therapeutic genes into nerve cells, providing targeted supply of …
for delivering therapeutic genes into nerve cells, providing targeted supply of …
[PDF][PDF] Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling, LPG Wheeler… - researchgate.net
Replication-deficient adeno-associated virus (AAV) or lentivirus vectors are powerful tools
for delivering therapeutic genes into nerve cells, providing targeted supply of …
for delivering therapeutic genes into nerve cells, providing targeted supply of …
Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF.
CJ LeVaillant, A Sharma, J Muhling… - … therapy. Methods & …, 2016 - europepmc.org
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
[引用][C] Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma… - Molecular …, 2016 - research-repository.uwa.edu.au
Significant changes in endogenous retinal gene expression assessed 1 year after a single
intraocular injection of AAV-CNTF or AAV-BDNF — the UWA Profiles and Research Repository …
intraocular injection of AAV-CNTF or AAV-BDNF — the UWA Profiles and Research Repository …
[HTML][HTML] Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling… - … Therapy. Methods & …, 2016 - ncbi.nlm.nih.gov
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling… - … Therapy. Methods & …, 2016 - search.proquest.com
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
[HTML][HTML] Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ LeVaillant, A Sharma, J Muhling… - … Therapy-Methods & …, 2016 - Elsevier
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
CJ Levaillant, A Sharma, J Muhling… - … Therapy. Methods & …, 2016 - search.proquest.com
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …
for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral …